Eugene

[email protected]

LATEST

PCI Pharma Services Appoints Chief Executive Officer
By

By
PCI Pharma Services, a Philadelphia, Pennsylvania-based pharmaceutical contract service provider, has appointed Salim Haffar, as Chief Executive Officer to take effect later in 2018. Haffar is currently President of Aptar…

AbbVie To Grant Mylan License to Launch Humira Biosimilar
By

By
AbbVie has signed patent license agreements with Mylan over Mylan’s proposed biosimilar to AbbVie’s Humira (adalimumab). Humira is AbbVie’s top-selling drug with 2017 sales of $18.43 billion. Under the agreements,…

FDA Issues Draft Guidance to Increase Access to OTC Drugs
By

By
The US Food and Drug Administration (FDA) has issued draft guidance, Innovative Approaches for Nonprescription Drug Products, as part of the agency’s effort to increase access to nonprescription drugs to…

AGC To Expand Chemical API Capacity
By

By
AGC, a Tokyo-headquartered manufacturer of glass and chemicals, is planning an expansion of its facilities in Chiba, Japan to increase the company’s manufacturing capacity for pharmaceutical intermediates and active pharmaceutical…

SK Holdings to Acquire CDMO Ampac Fine Chemicals
By

By
SK Holdings, a Seoul, South Korea-based holding company of SK Group, has agreed to acquire Ampac Fine Chemicals (AFC), a Rancho Cordova, California-headquartered contract manufacturer of active pharmaceutical ingredients (APIs)…

Catalent Appoints General Manager
By

By
Catalent Pharma Solutions has appointed Marlene Leuenberger as General Manager of the company’s Drug Development Center of Excellence in Somerset, New Jersey. Leuenberger has over 25 years’ management experience in…

Almac To Invest in Analytical Capabilities for Impurity Testing
By

By
Almac Group, a Craigavon, UK-based contract development and manufacturing organization (CDMO) of active pharmaceutical ingredients (APIs) and drug products, plans to invest £375,000 ($496,000) in additional nuclear magnetic resonance (NMR)…

AstraZeneca in Gene-Therapy Pact
By

By
MedImmune, AstraZeneca’s global biologics research and development arm, has partnered with 4D Molecular Therapeutics (4DMT), a company specializing in gene-therapy vector discovery and product development, to develop and commercialize a…

Dr. Reddy’s To Appeal Injunction Against Anti-Opioid Dependence Drug
By

By
Dr. Reddy’s Laboratories, a Hyderabad, India-headquartered pharmaceutical company, has announced its intent to appeal a preliminary injunction made by a federal US district court against further sales and commercialization of…

Novartis Partners with French CDMO for CAR-T-Cell Therapy Mfg
By

By
Novartis has signed an agreement with CELLforCURE, a contract development and manufacturing organization and part of the biopharmaceutical company, LFB, to produce chimeric antigen receptor T-cell (CAR-T) therapies at CELLforCURE’s…